{"organizations": [], "uuid": "dad9e36da9d20d59a54138f8f27e046ecadd5980", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-8774/social", "site_section": "http://online.wsj.com/xml/rss/3_7014.xml", "section_title": "WSJ.com: US Business", "url": "https://www.wsj.com/articles/pfizer-revenue-growth-stalls-1525174796", "country": "US", "domain_rank": 387, "title": "Pfizer Revenue Growth Stalls", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-01T15:39:00.000+03:00", "replies_count": 0, "uuid": "dad9e36da9d20d59a54138f8f27e046ecadd5980"}, "author": "Cara Lombardo", "url": "https://www.wsj.com/articles/pfizer-revenue-growth-stalls-1525174796", "ord_in_thread": 0, "title": "Pfizer Revenue Growth Stalls", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "pfizer revenue growth stalls pfizer inc.", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Pfizer Inc.â€™s revenue was little changed in its latest quarter as the pharmaceutical company examines the future of its consumer-health business.\nPfizer said Tuesday its first-quarter revenue increased 1% from a year ago to $12.91 billion, less than the $13.13 billion analysts expected. Revenue increased in its innovative health unit, which is slightly more than half the business and includes its consumer-health brands such as Advil, Chapstick and Centrum vitamins. But it decreased in its essential health unit, which the... To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-05-01T15:39:00.000+03:00", "crawled": "2018-05-01T16:03:11.021+03:00", "highlightTitle": ""}